Marker Therapeutics, Inc.

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indic…

Biotechnology

US, Houston [HQ]

Summary
IR
Fin. Reports
Financials
Leadership & Strategy
Possible Catalysts

Board & Officers
Business Intelligence
Employee Voice
Mergers and Acquisitions
Qualified Risks
ESG Scores [Soon]

Strategy & Leadership

Mergers & Acquisitions Beta

M&As

MRKR M&As
Biotechnology M&A

M&A Deals · Breakdown

Marker Therapeutics, Inc. has no acquisition track records yet.

M&A Deals · History

Marker Therapeutics, Inc. has no acquisition track records yet.